Our recent work focused on the elucidation of inflammatory responses to respiratory viruses, with specific interest in the role of eosinophilic leukocytes in host defense against respiratory virus pathogens in vivo [1, 2]. As part of these studies, we identified pneumonia virus of mice (PVM) as an important and relevant pathogen for studies in rodent hosts. PVM is a member of the family Paramyxoviridae, subfamily Pneumovirinae, and is the closest known phylogenetic relative to the human pneumovirus pathogen, respiratory syncytial virus (RSV). However, unlike RSV, PVM is a natural pathogen of rodents, and responses to PVM in experiments in rodent hosts are thus more meaningful from both physiologic and evolutionary perspectives [2, 3] . We have found that inoculation of wild-type mice with as few as 30 pfu of PVM results in a respiratory infection reminiscent of the most severe forms of RSV in human infants, with profound granulocytic bronchiolitis, which ultimately leads to respiratory failure and death [4, 5] . We identified the
Our recent work focused on the elucidation of inflammatory responses to respiratory viruses, with specific interest in the role of eosinophilic leukocytes in host defense against respiratory virus pathogens in vivo [1, 2] . As part of these studies, we identified pneumonia virus of mice (PVM) as an important and relevant pathogen for studies in rodent hosts. PVM is a member of the family Paramyxoviridae, subfamily Pneumovirinae, and is the closest known phylogenetic relative to the human pneumovirus pathogen, respiratory syncytial virus (RSV). However, unlike RSV, PVM is a natural pathogen of rodents, and responses to PVM in experiments in rodent hosts are thus more meaningful from both physiologic and evolutionary perspectives [2, 3] . We have found that inoculation of wild-type mice with as few as 30 pfu of PVM results in a respiratory infection reminiscent of the most severe forms of RSV in human infants, with profound granulocytic bronchiolitis, which ultimately leads to respiratory failure and death [4, 5] . We identified the CC chemokine macrophage inflammatory protein (MIP)-1a and its receptor CCR1 as crucial regulators of this inflammatory response and as important mediators of antiviral host defense [6] ; MIP-1a has also been implicated in the pathogenesis of severe RSV infection in humans [7, 8] .
In this study, we compared the responses of wild-type mice to infection with 2 distinct strains of PVM-the pathogenic, continually mouse-passaged strain J3666, which is used in the studies described above and in that of Cook et al. [9] , and strain 15, a variant rendered nonpathogenic by repeated passage in tissue culture [10] . The responses evaluated include clinical symptoms, viral replication, microscopic pathology, and production of proinflammatory chemokines in lung tissue of infected mice. To provide a more comprehensive view of differential gene expression in lung tissue, we present the results of a 3-way microarray comparison of lung mRNAs expressed in uninfected control mice, compared with those from mice infected with either the pathogenic strain J3666 or with the nonpathogenic strain 15 virus. As part of this analysis, we discuss the microarray approach for the study of inflammatory responses in vivo.
Materials and Methods
Mouse and virus stocks. Male and female C57black/6 mice (6-8 weeks old) were used in all experiments. Mouse-passaged stocks of both strains of PVM (J3666 and 15) at pfu/mL, as 5 3-5 ϫ 10 determined by standard plaque assay on BS-C-1 epithelial cells (American Type Culture Collection), were stored in liquid nitrogen.
Establishing and evaluating lower respiratory tract infection in On the days indicated after infection, mice were killed by cervical dislocation, and lungs to be sectioned for microscopic analysis were inflated transbronchially with ∼0.3 mL of 10% formalin prior to fixation and hematoxylin-eosin (HE) staining (American Histolabs). Lungs to be processed for ELISA and virus titer determination were removed from the body cavity under aseptic conditions and immersed in prechilled IMDM. After blade homogenization (Tissumizer; Tekmar) and centrifugation, clarified supernatants were flash frozen on dry ice-ethanol and stored at Ϫ80ЊC before use. Virus titers were determined by standard plaque assay, as described above. Concentrations of MIP-1a and monocyte chemoattractant peptide (MCP)-1 were determined by commercial ELISA (R&D Systems), according to the manufacturer's instructions. Total protein was determined by the Bradford colorimetric assay. Bronchoalveolar lavage (BAL) fluid was collected, as described elsewhere [4] . Total and differential leukocyte counts were assessed by visual inspection of methanol-fixed, Diff-Quik stained cytospin preparations.
Preparation of total lung RNA. For preparation of samples for microarray analysis, lungs were removed from uninfected (shaminoculated) mice and from mice infected with PVM strain 15 or strain J3666 on postinoculation day 3, flash-frozen in dry iceethanol, and immersed in 7 ml of RNazol reagent (Teltest). After blade homogenization, chloroform was added (1:10 vol/vol), and the specimen was mixed thoroughly and incubated on ice for 15 min. After a 30-min centrifugation at 13,600 g, the aqueous layer was transferred to fresh tubes. Equal volumes of ice-cold isopropanol were added, and RNA was precipitated at Ϫ20ЊC. Total RNA was pelleted, washed twice in 80% ethanol, dried, and resuspended in diethyl pyrocarbonate-treated water. RNA was quantitated spectrophotometrically. Only samples with absorbance at 260 nm:absorbance at 280 nm ratios of 1.8-2.1 were used for further studies. These were treated with RNase-free DNase I (Roche Diagnostics) to remove any traces of genomic DNA prior to preparation of cRNA. Sample integrity was further confirmed by formaldehyde-agarose gel electrophoresis. RNA samples from lungs of 5 mice per condition were pooled to reduce any effects of intrinsic biologic variability.
Microarray analysis of mouse lung RNA. All microarray procedures were done at the Microarray Core Facility (Rochester, NY). In brief, RNA (2-5 mg) was reverse transcribed to cDNA (Superscript II; Life Technologies) by using a T7-(dT)24 oligomer. The introduced T7 promoter provided the necessary template for in vitro cRNA synthesis by use of bacteriophage T7 RNA polymerase in the presence of biotinylated nucleotides. The labeled cRNA were then hybridized to a test array containing common housekeeping genes (b-actin, glyceraldehyde-3-phosphate dehydrogenase, transferrin receptor, and rRNA). This confirmed successful labeling of representative undegraded target RNA samples. Hybridization of the U74A mouse gene microarray chip (Affymetrix) was done in the Affymetrix Fluidics station 400 by use of the recommended expression analysis protocol.
For these experiments, 3 prokaryotic genes (bioB, bioC, and bioD) were added to the hybridization cocktail as internal controls. Gene chips were stained with phycoerythrin-streptavidin (10 mg/ mL) and scanned with an Agilent GeneArray scanner. For each gene, 12-20 probe pairs were included, and each was expected to hybridize to different regions of the labeled cRNA. Each probe pair was represented as a perfect match (PM) or a single-base mismatch (MM) used as hybridization controls. The average intensity of each probe cell was calculated after correction for background fluorescence. This normalized average intensity value was used to determine the number of positive and negative probe pairs for each cRNA. On the basis of the positive:negative ratios, the positive fraction and the log average ratio of the PM to the MM, an absolute call was determined as "present" or "absent." Mean differences were determined by calculating the difference in intensity between the PM and the MM of every probe pair and averaging the differences over the entire probe set. The mean difference statistic was retrieved for quantification of mRNA abundance in those samples in which the absolute call indicated that the gene was present. Gene expression patterns among the different experimental conditions were compared with Affymetrix Microarray Suite software (version 4.0). Separate experiments for each comparison were done twice.
Additional data analyses. Clinical scoring of infected mice was done as described by Cook et al. [9] , with mice given scores for clinical symptomatology, as follows: 1, healthy; 2, ruffled fur at neck; 3, piloerection and difficulty breathing, less alert; 4, lethargic with labored breathing; 5, premorbid with emaciation and cyanosis; and 6, death. In contrast to the aforementioned study, we modified the system so as to score all mice entered into the study at every time point (i.e., mice that died on day 5 receiving a score of 6 were counted with a score of 6 on all days thereafter). All other data points with error bars represent the of samples from mean ‫ע‬ SEM у3 mice. Statistical significance was determined by paired and unpaired t tests as per the algorithms of the Microsoft Excel data analysis program.
Results

Clinical symptoms and viral replication.
To assess the sequelae of infection with each PVM strain, mice were inoculated on day 0 with 200 pfu of PVM strain 15 or 200 pfu of strain
J3666 (
). Strain 15 has been described as replin p 10/group cation-competent but nonpathogenic [9, 10] , whereas infection with J3666 is characterized by profound morbidity and significant mortality observed in response to inoculation with as few as 30 pfu [4, 9] . The mean clinical score of all mice assessed on each day was determined by a modification of the method of Cook et al. [9] , as described in Materials and Methods, with conditions ranging from no symptoms (score 1) to death (score 6; figure 1A ). Mice infected with 200 pfu of J3666 succumbed rapidly, with 100% mortality observed by postinoculation day 7. In contrast, several (but not all) mice inoculated with strain 15 had ruffled neck fur on postinoculation days 4-6 but, ultimately, became symptom free, with no mortality observed up to and including day 10. Of interest, replication of both virus strains was indistinguishable through day 5 and peaked at ∼10 8 pfu/g of lung tissue (figure 1B). Then the virions from mice infected with strain 15 were gradually cleared and none were detected by day 10 (data not shown).
Microscopic pathology. Figure 2 shows HE-stained lung tissue sections from mice infected with strain 15 or strain J3666 and harvested on postinoculation day 4. Figure 2A depicts a typical field from a lung of a mouse infected with strain 15, with relatively normal architecture, a few leukocytes, and scant proteinaceous pink-staining infiltrate; one field with more prominent evidence of infiltrate was detected (figure 2B) in a mouse that exhibited mild symptoms, analogous to those receiving a clinical score of 2 (see Materials and Methods and figure 1 ). In contrast, the lungs of mice infected with J3666 displayed a more distinct pathology with significant obliteration of the airspaces (particularly at the periphery) and a prominent cellular inflammatory response. The granulocytes within the infiltrates in the strain J3666-infected mouse lungs were seen more clearly at higher magnification ( figure 2D) .
Analysis of inflammatory infiltrate. Table 1 lists the cellular composition of BAL fluid from mice infected with strains 15 and J3666. BAL fluid from strain 15-infected mice contained ∼ leukocytes/mL at all time points tested. In contrast, 2 2 ϫ 10 we observed a marked increase in total leukocytes in BAL fluid on day 3 after inoculation with strain J3666 to ∼ leu- 5 5 ϫ 10 kocytes/mL, with virtually 100% of the cells identified as granulocytes (eosinophils at ∼10%-15% on day 3).
Detection of proinflammatory chemokines.
In previous work, we identified the CC chemokine MIP-1a as a crucial regulator of the inflammatory response to PVM strain J3666 infection as mice deficient in either MIP-1a (MIP-1a Ϫ/Ϫ ) or its major receptor, CCR1 (CCR1 Ϫ/Ϫ ), were unable to mount an inflammatory response, which left viral replication unchecked and led to accelerated mortality, as shown among the latter set of mice [6] . In contrast, despite ongoing viral replication, we were unable to detect MIP-1a in lung tissue in response to infection with either 200 pfu or 5000 pfu inoculations of strain 15 (table 2) . Similarly, we were unable to detect synthesis of MCP-1 in response to strain 15 infection (both 200 pfu and 5000 pfu inocula), despite prominent production in response to infection with J3666 [11] . Priming mice with PVM strain 15 (200 pfu at Ϫ14 days) had no effect on the production of chemokines MIP-1a and MCP-1 (table 3) .
Microarray analysis. To provide a more thorough analysis of genes expressed in response to these 2 different PVM strains, on postinoculation day 3, we probed the murine genome U74 microarray from Affymetrix, which includes sequences from 12,000 mouse genes, with radiolabeled cRNA prepared from total lung tissue from uninfected, strain 15-infected, and strain J3666-infected mice and evaluated relative expression via a 3-way cross (see Materials and Methods). Of the 12,000 transcripts evaluated, we detected a total of 87 sequences whose expression was increased у3-fold in a comparison of strain J3666 infection versus uninfected control mice. Of these 87 sequences, 55 encode known gene products (as indicated by GenBank listings).
Here, we focused primarily on the gene products related to promoting and sustaining the antiviral inflammatory response. Of the 55 known genes that we identified as up-regulated у3-fold in response to J3666 infection, 5 encode proinflammatory cytokines, including interferon (IFN)-1b, and an additional 12 are regulators of and/or regulated by IFN (table 4). Our identification of IFN response genes was augmented to include metallothionein (K02236) and MCP-1 (M19861) by comparison of our list of differentially expressed transcripts with those identified in IFN-stimulated human cells by Der et al. [12] , de Veer et al. [13] , and Williams (http://www.lerner.ccf.org/labs/ williams/).
We detected no increase in transcripts encoding IFN-a (1, 4, 5, 6, 7, 8, or 11) or IFN-g. Of interest, only about half as many genes are up-regulated to the same extent (39 total, 16 known) in response to infection with strain 15, and very few are found in common between the 2. We observed no increased expression of IFN-1b or of any of the IFN response genes in mice infected with strain 15. Among the proinflammatory cytokines, only RANTES (ScyA5) mRNA levels were increased to a similar extent in response to both infections. The increases in the levels of mRNA encoding RANTES and eotaxin were surprising, Table 3 . Detection of proinflammatory chemokines macrophage inflammatory protein (MIP)-1a and monocyte chemoattractant peptide (MCP)-1 (both in pg/mL/mg protein) in lung tissue from mice inoculated (primed) on day Ϫ14 with 200 pfu of the nonpathogenic pneumonia virus of mice (PVM) strain 15 or diluent (Iscove's modified Dulbecco's medium) control, followed by inoculation on day 0 with 200 pfu of the pathogenic PVM strain J3666. given our previous findings on protein levels in response to infection with J3666 (see Discussion). An unexpected and potentially interesting finding is the altered regulation of expression of mRNA encoding a small proline-rich protein (Sprr)1A, which was up-regulated 6-fold in response to the pathogenic J3666 infection, and down-regulated 11-fold in response to infection with strain 15. We were intrigued by the differential regulation of this transcript (previously characterized as encoding an epithelial protein expressed in relation to dermal cornification and carcinogenesis [14] [15] [16] ) in response to pathogenic versus nonpathogenic virus infection. Although it is not clear whether PVM infection results in syncytia formation in vivo, we would not be surprised to find a role for this protein similar to that observed for cytokeratin-17, a protein that is up-regulated in response to RSV infection in vitro and expressed uniquely at the sites of cell fusion or syncytia formation [17] .
Discussion
Here, we examined the responses of wild-type mice to infection with 2 distinct strains of the natural mouse pneumovirus pathogen, PVM. Consistent with our earlier findings, intranasal inoculation with 200 pfu of strain J3666 resulted in a uniformly fatal infection, accompanied by granulocytic inflammatory response and production of the proinflammatory chemokines MIP-1a and MCP-1. In contrast, the identical inoculum of strain 15 resulted in minimal symptoms and little to no inflammatory response despite clear evidence of viral replication in lung tissue.
Most of the published PVM sequence data were derived from genes obtained from isolates of strain 15 [18] [19] [20] [21] [22] [23] [24] . However, the sequences of the attachment (G) and fusion (F) proteins are available for both PVM strains. Randhawa et al. [10] reported that the F proteins differed by only 4 amino acid residues. However, the G proteins were substantially different due to the existence of distinct translational start sites in the G genes of the 2 strains, resulting in the absence of a putative amino-terminal cytoplasmic domain in the G protein of strain 15. The remaining extracellular portion of the G proteins contained only 2 amino acid differences. Once complete genome sequence data for both strains are available, it will be of interest to determine the molecular basis via which immunologically naive mice can discern between these 2 strains of infectious virus and what elements of cellular metabolism are perturbed by which virus component(s) in order to trigger the inflammatory response.
As part of this work, we present a microarray study that assessed the sequelae of pneumovirus infection in lung tissue in vivo, and we have evaluated the results with a specific focus on the elements related to the antiviral inflammatory response. It was not surprising to find IFN-1b and IFN-related transcripts as being among the most prominent responses to infection with the pathogenic PVM strain J3666, but it is intriguing that no IFN or IFN-related responses to the nonpathogenic strain 15 were apparent, despite clear evidence of its replication in lung tissue. IFN-a (1, 4, 5, 6, 7, 8 and 11) and IFN-g were included in the 12,000-transcript screen but were not up-regulated in response to either virus infection. IFNs and their role in limiting the sequelae of viral infection have been the subject of much research (reviewed in [25] [26] [27] ), and enhanced expression of IFNs and IFN-related transcripts have been observed in at least 2 microarray studies of virus infection in tissue culture [28, 29] and in 1 study that assessed the response to adenovirus-vector expression in liver in vivo [30] . Recently, the NS1 and NS2 genes of bovine RSV were shown to act together to inhibit the host type 1 IFN response to infection by an unknown mechanism [31] ; the NS1 and NS2 genes of both PVM strains are identical in nucleotide sequence (A.J.E., unpublished data).
Proinflammatory chemokines were another major group of transcripts whose expression was induced by strain J3666 but not by strain 15, including MCP-1, MCP-3, and eotaxin. As noted earlier, MCP-1 is also an IFN response gene [29] . This list is similar to, but not completely overlapping with, that reported by Zhang et al. [32] for cells of the human A549 bronchial epithelial line infected with the human pathogen, RSV.
Of interest, RANTES expression was increased equally in mice infected with strains J3666 and 15, suggesting that it is either insufficient when acting alone or not directly related to the inflammatory response to PVM in vivo. Although the screen demonstrated increased expression of mRNAs encoding both RAN-TES and eotaxin in response to J3666 infection, we previously showed that both proteins are present at relatively high concentration in lung tissue of uninfected mice ( and 620 ‫ע‬ 120 pg/mL/mg protein, respectively), with no significant 460 ‫ע‬ 70 change observed during the course of viral infection [4] . Similarly, we have also observed significant increases in expression of inducible nitric oxide synthase protein in response to J3666 infection [11] , while no change in expression of the transcript was observed on the microarray screen. This apparent discordance between changes in mRNA and resulting protein expression underscores the importance of protein-based immunologic and activity assays in the ultimate functional characterization of any of the responses detected via microarray analysis.
